Sai Life Sciences Limited reports robust quarterly results
Revenue grows by 15%; Net Profit up 36% year-on-year Hyderabad, February 7, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused,
Revenue grows by 15%; Net Profit up 36% year-on-year Hyderabad, February 7, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused,
Mumbai, 20th June 2024: Plasmagen Biosciences Private Limited (“Plasmagen”), the Indian biopharmaceutical organization, headquartered in Bengaluru, specializing exclusively in Plasma Protein and Speciality Care Therapy, has recently